Regeneron Pharmaceuticals
Utility Patent Applications
Last updated:
List of all Regeneron Pharmaceuticals patents 168 in total
| Status | Patent |
|---|---|
Application | Utility: Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders Filling date: 5 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: HSD17B13 Variants And Uses Thereof Filling date: 5 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN Filling date: 5 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHOD FOR VIRAL INACTIVATION Filling date: 5 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHOD AND SYSTEM OF IDENTIFYING AND QUANTIFYING A PROTEIN Filling date: 5 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: MODIFIED DOSAGE OF SUBCUTANEOUS TOCILIZUMAB FOR RHEUMATOID ARTHRITIS Filling date: 5 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION THROUGH SINGLE-STEP MULTIPLE TARGETING Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: NOVEL ANTIGEN BINDING MOLECULE FORMATS Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: Methods Of Improving Health With Apolipoprotein E (APOE) Inhibitors Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 5 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 5 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: Rodent Model Of Increased Bone Mineral Density Filling date: 5 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences Filling date: 5 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A Filling date: 5 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: ANTI-NPR1 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: AUTO-INJECTOR AND RELATED METHODS OF USE Filling date: 5 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: METHODS FOR TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 5 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: NOVEL ANTIGEN BINDING MOLECULE FORMATS Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: AUTO-INJECTOR AND RELATED METHODS OF USE Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: SYSTEMS AND METHODS FOR SIGNAL BASED FEATURE ANALYSIS TO DETERMINE CLINICAL OUTCOMES Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: NUCLEIC ACIDS ENCODING ANCHOR MODIFIED ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED TSLP GENE, A HUMANIZED TSLP RECEPTOR GENE, AND/OR A HUMANIZED IL7RA GENE Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: Methods for Identification of Scrambled Disulfides in Biomolecules Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: IMMUNOGLOBULIN PROTEINS THAT BIND TO NPR1 AGONISTS Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) Inhibitors Filling date: 5 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: HUMAN ANTIBODIES THAT BIND RET AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: CELL CULTURE MEDIUM FOR EUKARYOTIC CELLS Filling date: 5 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: NON-HUMAN ANIMALS HAVING AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION THAT INCLUDES AN ENGINEERED DIVERSITY CLUSTER AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE Filling date: 5 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: MICE THAT MAKE VL BINDING PROTEINS Filling date: 5 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: Methods Of Identifying Subjects Having An Increased Risk Of Developing A Coronavirus Infection And Treatment Thereof Filling date: 5 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES Filling date: 5 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: METHODS FOR TREATING ASTHMA IN PEDIATRIC SUBJECTS BY ADMINISTERING AN IL-4R ANTAGONIST Filling date: 5 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 5 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: ANTI-IL36R ANTIBODIES Filling date: 5 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: ANTI-FGFR2 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: Genotyping By Sequencing Filling date: 5 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: UNBIASED AND HIGH-THROUGHPUT IDENTIFICATION AND QUANTIFICATION OF HOST CELL PROTEIN IMPURITIES BY AUTOMATED ITERATIVE LC-MS/MS (HCP-AIMS) FOR THERAPEUTIC PROTEIN DEVELOPMENT Filling date: 5 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN Filling date: 5 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules that Bind CD3 and CD20, and Uses Thereof Filling date: 5 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF Filling date: 5 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: RODENT ANIMALS EXPRESSING HUMAN CR1 Filling date: 5 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: ANTIBODY-DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME Filling date: 5 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: METHODS FOR TREATING OR PREVENTING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF ANGPTL3 Filling date: 5 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF Filling date: 5 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: IDENTIFICATION AND PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODIES Filling date: 5 Sep 2025 Issue date: 24 Mar 2022 |
Showing 1 to 50 of 168 patents.